MicroTech Medical Hangzhou Co Ltd
HKEX:2235

Watchlist Manager
MicroTech Medical Hangzhou Co Ltd Logo
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Watchlist
Price: 6.05 HKD 2.2% Market Closed
Market Cap: 2.5B HKD

MicroTech Medical Hangzhou Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MicroTech Medical Hangzhou Co Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Total Equity
ÂĄ2B
CAGR 3-Years
-4%
CAGR 5-Years
56%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Total Equity
ÂĄ1.9B
CAGR 3-Years
61%
CAGR 5-Years
48%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Total Equity
ÂĄ12.5B
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
22%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Total Equity
ÂĄ37.1B
CAGR 3-Years
13%
CAGR 5-Years
16%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Total Equity
ÂĄ15.8B
CAGR 3-Years
10%
CAGR 5-Years
16%
CAGR 10-Years
18%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Total Equity
ÂĄ18.9B
CAGR 3-Years
74%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

MicroTech Medical Hangzhou Co Ltd
Glance View

Market Cap
2.5B HKD
Industry
Health Care

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.

Intrinsic Value
2.25 HKD
Overvaluation 63%
Intrinsic Value
Price

See Also

What is MicroTech Medical Hangzhou Co Ltd's Total Equity?
Total Equity
2B CNY

Based on the financial report for Dec 31, 2024, MicroTech Medical Hangzhou Co Ltd's Total Equity amounts to 2B CNY.

What is MicroTech Medical Hangzhou Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
56%

Over the last year, the Total Equity growth was -4%. The average annual Total Equity growth rates for MicroTech Medical Hangzhou Co Ltd have been -4% over the past three years , 56% over the past five years .

Back to Top